AR036358A1 - Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma - Google Patents
Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asmaInfo
- Publication number
- AR036358A1 AR036358A1 ARP020103194A ARP020103194A AR036358A1 AR 036358 A1 AR036358 A1 AR 036358A1 AR P020103194 A ARP020103194 A AR P020103194A AR P020103194 A ARP020103194 A AR P020103194A AR 036358 A1 AR036358 A1 AR 036358A1
- Authority
- AR
- Argentina
- Prior art keywords
- formulation
- product
- asthma
- inhalation
- manufacture
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title abstract 7
- 239000000203 mixture Substances 0.000 title abstract 7
- 238000004519 manufacturing process Methods 0.000 title abstract 4
- 239000000443 aerosol Substances 0.000 title abstract 2
- 208000006673 asthma Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000000725 suspension Substances 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- OBRNDARFFFHCGE-PERKLWIXSA-N (S,S)-formoterol fumarate Chemical compound OC(=O)\C=C\C(O)=O.C1=CC(OC)=CC=C1C[C@H](C)NC[C@@H](O)C1=CC=C(O)C(NC=O)=C1.C1=CC(OC)=CC=C1C[C@H](C)NC[C@@H](O)C1=CC=C(O)C(NC=O)=C1 OBRNDARFFFHCGE-PERKLWIXSA-N 0.000 abstract 5
- 229960000193 formoterol fumarate Drugs 0.000 abstract 5
- 229960002744 mometasone furoate Drugs 0.000 abstract 5
- WOFMFGQZHJDGCX-ZULDAHANSA-N mometasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2C[C@H]1C)C(=O)CCl)C(=O)C1=CC=CO1 WOFMFGQZHJDGCX-ZULDAHANSA-N 0.000 abstract 5
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940071648 metered dose inhaler Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Un inhalador de dosis medidas que contiene una formulación de suspensión en aerosol para inhalación, que comprende: una cantidad eficaz de mometasona furoato; una cantidad eficaz de formoterol fumarato; y 1,1,1,2,3,3,3-heptafluopropano; en donde la relación de mometasona furoato a formoterol fumarato es aproximadamente 400 microgramos de mometasona furoato a aproximadamente 12 microgramos de formoterol fumarato, a aproximadamente 50 microgramos de mometasona furoato a aproximadamente 6 microgramos de formoterol fumarato, en donde el formoterol fumarato se convierte en una masa floculenta con la mometasona furoato, y en donde la formulación está sustancialmente libre de un portador, un proceso para la producción de formulación, el producto y el uso de una formulación par la manufactura de un medicamento para el tratamiento de asma.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31538601P | 2001-08-28 | 2001-08-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR036358A1 true AR036358A1 (es) | 2004-09-01 |
Family
ID=23224164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020103194A AR036358A1 (es) | 2001-08-28 | 2002-08-26 | Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US20030114428A1 (es) |
| EP (3) | EP2092935B1 (es) |
| JP (3) | JP2005502675A (es) |
| KR (1) | KR100970531B1 (es) |
| CN (2) | CN101856362A (es) |
| AR (1) | AR036358A1 (es) |
| AT (2) | ATE430555T1 (es) |
| AU (1) | AU2002313828B2 (es) |
| BR (1) | BR0212089A (es) |
| CA (1) | CA2457926A1 (es) |
| CO (1) | CO5560551A2 (es) |
| CY (2) | CY1109212T1 (es) |
| DE (2) | DE60232251D1 (es) |
| DK (2) | DK2092935T3 (es) |
| ES (3) | ES2325316T3 (es) |
| HU (1) | HUP0401514A3 (es) |
| MX (1) | MXPA04001875A (es) |
| NO (1) | NO20041277L (es) |
| NZ (1) | NZ530987A (es) |
| PE (1) | PE20030390A1 (es) |
| PL (1) | PL209640B1 (es) |
| PT (2) | PT2092935E (es) |
| SI (2) | SI2092935T1 (es) |
| TW (1) | TWI324934B (es) |
| WO (1) | WO2003020253A2 (es) |
| ZA (1) | ZA200401419B (es) |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9904919D0 (en) * | 1999-03-03 | 1999-04-28 | Novartis Ag | Organic compounds |
| PT1372608E (pt) * | 2001-03-30 | 2008-01-04 | Jagotec Ag | Formulações de aerossol médicas |
| GB0207906D0 (en) | 2002-04-05 | 2002-05-15 | 3M Innovative Properties Co | Formoterol and mometasone aerosol formulations |
| DE60311665T2 (de) * | 2002-08-23 | 2007-10-25 | Schering Corp. | Pharmazeutische zusammensetzungen |
| EP1785156B1 (en) * | 2002-08-23 | 2012-06-27 | Schering Corporation | Metered dose inhaler containing an aerosol suspension formulation |
| ATE503687T1 (de) * | 2002-08-27 | 2011-04-15 | Schering Corp | Verfahren zur herstellung von formulierungen für inhaliergeräte mit abgemessener dosis |
| GB0323684D0 (en) | 2003-10-09 | 2003-11-12 | Jagotec Ag | Improvements in or relating to organic compounds |
| GB0323685D0 (en) * | 2003-10-09 | 2003-11-12 | Jagotec Ag | Improvements in or relating to organic compounds |
| EP1925293A3 (en) * | 2003-10-20 | 2010-01-13 | Schering Corporation | Pharmaceutical aerosol compositions |
| SG147453A1 (en) * | 2003-10-20 | 2008-11-28 | Schering Corp | Pharmaceutical aerosol compositions |
| WO2005072704A2 (en) * | 2004-01-21 | 2005-08-11 | Schering Corporation | Method of treating acute rhinosinusitis |
| US20110053999A1 (en) | 2004-03-03 | 2011-03-03 | Daley Thomas E | 4-methylpyrazole formulations for inhibiting ethanol intolerance |
| DE602005009012D1 (de) * | 2004-10-12 | 2008-09-25 | Generics Uk Ltd | Rmulierungen, worin die partikel durch präzipition in einem aerosolbehälter gebildet werden |
| MX2007012084A (es) | 2005-03-30 | 2007-11-21 | Schering Corp | Medicamentos y metodos que combinan un anticolinergico, un corticosteroide y un agonista beta de accion prolongada. |
| AR059357A1 (es) * | 2006-02-09 | 2008-03-26 | Schering Corp | Formulaciones farmaceuticas |
| US20080253970A1 (en) * | 2007-02-09 | 2008-10-16 | Schering Corporation | Stable Pharmaceutical Drug Products |
| JP2010518076A (ja) * | 2007-02-09 | 2010-05-27 | シェーリング コーポレイション | 安定な医薬エアロゾル製剤 |
| GB0714239D0 (en) * | 2007-07-20 | 2007-08-29 | Glaxo Group Ltd | Method |
| EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
| WO2009089422A2 (en) * | 2008-01-10 | 2009-07-16 | Schering Corporation | Inhalation drug products, systems and uses |
| GB0801876D0 (en) | 2008-02-01 | 2008-03-12 | Vectura Group Plc | Suspension formulations |
| WO2010112358A2 (de) | 2009-03-31 | 2010-10-07 | Boehringer Ingelheim International Gmbh | Verfahren zur beschichtung einer oberfläche eines bauteils |
| EP3508239B1 (de) | 2009-05-18 | 2020-12-23 | Boehringer Ingelheim International GmbH | Adapter, inhalationseinrichtung und zerstäuber |
| TWI792140B (zh) * | 2009-05-29 | 2023-02-11 | 美商沛爾醫療股份有限公司 | 用於經由呼吸道遞送二或更多種活性藥劑的組成物、方法與系統 |
| US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
| WO2011027247A1 (en) | 2009-09-03 | 2011-03-10 | Sulur Subramaniam Vanangamudi | An antifungal cream comprising terbinafine hydrochloride |
| GB0918149D0 (en) | 2009-10-16 | 2009-12-02 | Jagotec Ag | Improved medicinal aerosol formulation |
| WO2011064163A1 (en) | 2009-11-25 | 2011-06-03 | Boehringer Ingelheim International Gmbh | Nebulizer |
| AU2010323220B2 (en) | 2009-11-25 | 2015-04-23 | Boehringer Ingelheim International Gmbh | Nebulizer |
| US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
| ES2646201T3 (es) * | 2009-12-07 | 2017-12-12 | Horizon Orphan Llc | Formulaciones de 4-metilpirazol |
| WO2011101828A1 (en) | 2010-02-22 | 2011-08-25 | Sulur Subramaniam Vanangamudi | A medicinal fusidic acid cream made using sidium fusidate and incorporating a biopolymer and betamethasone, and a process to make it |
| WO2011101830A1 (en) | 2010-02-22 | 2011-08-25 | Sulur Subramaniam Vanangamudi | A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and clobetasone, and a process to make it |
| US9943654B2 (en) | 2010-06-24 | 2018-04-17 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2012017368A1 (en) | 2010-08-02 | 2012-02-09 | Sulur Subramaniam Vanangamudi | A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, beclomethasone dipropionate and a process to make it |
| WO2012049543A1 (en) | 2010-10-15 | 2012-04-19 | Sulur Subramaniam Vanangamudi | A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a corticosteroid, and a process to make it |
| EP2694220B1 (de) | 2011-04-01 | 2020-05-06 | Boehringer Ingelheim International GmbH | Medizinisches gerät mit behälter |
| US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
| CA2850084C (en) * | 2011-10-11 | 2020-07-07 | Chiesi Farmaceutici S.P.A. | Crystalline microparticles of a beta-agonist coated with a fatty acid |
| WO2013152894A1 (de) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Zerstäuber mit kodiermitteln |
| TR201902687T4 (tr) | 2013-03-15 | 2019-03-21 | Pearl Therapeutics Inc | İri parçacıklı kristal malzemelerin koşullandırılması için yöntemler ve sistemler. |
| JP6643231B2 (ja) | 2013-08-09 | 2020-02-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネブライザ |
| ES2836977T3 (es) | 2013-08-09 | 2021-06-28 | Boehringer Ingelheim Int | Nebulizador |
| SG11201608891RA (en) | 2014-05-07 | 2016-11-29 | Boehringer Ingelheim Int | Nebulizer, indicator device and container |
| EP3139979B1 (en) | 2014-05-07 | 2023-07-05 | Boehringer Ingelheim International GmbH | Unit, nebulizer and method |
| US10722666B2 (en) | 2014-05-07 | 2020-07-28 | Boehringer Ingelheim International Gmbh | Nebulizer with axially movable and lockable container and indicator |
| ES2952510T3 (es) | 2014-06-30 | 2023-10-31 | Proveris Scient Corporation | Aparato de muestreo para determinar la cantidad y uniformidad de una dosis administrada de medicamento y métodos relacionados |
| ES2796177T5 (es) | 2015-12-04 | 2024-10-29 | Mexichem Fluor Sa De Cv | Composición farmacéutica |
| GB2545025A (en) * | 2015-12-04 | 2017-06-07 | Mexichem Fluor Sa De Cv | Pharmaceutical composition |
| CA3016890A1 (en) | 2016-03-09 | 2017-09-14 | Proveris Scientific Corporation | Methods for measuring dose content uniformity performance of inhaler and nasal devices |
| CN106619658B (zh) * | 2016-12-28 | 2022-02-08 | 四川普锐特药业有限公司 | 一种医用气溶胶制剂及定量吸入气雾剂 |
| US20210338626A1 (en) | 2020-04-28 | 2021-11-04 | Dalcor Pharma Uk Ltd., Leatherhead, Zug Branch | Methods for treating or preventing a viral infection or inhibiting viral replication |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5874063A (en) * | 1991-04-11 | 1999-02-23 | Astra Aktiebolag | Pharmaceutical formulation |
| ATE134509T1 (de) * | 1991-06-10 | 1996-03-15 | Schering Corp | Fluorchlorkohlenwasserstoffreie aerosolformulierungen |
| US6250300B1 (en) * | 1992-12-11 | 2001-06-26 | Ab Astra | System for dispensing pharmaceutically active compounds |
| US6932962B1 (en) * | 1994-12-22 | 2005-08-23 | Astrazeneca Ab | Aerosol drug formulations containing hydrofluoroalkanes and alkyl saccharides |
| GB9612297D0 (en) * | 1996-06-11 | 1996-08-14 | Minnesota Mining & Mfg | Medicinal aerosol formulations |
| CZ294064B6 (cs) * | 1996-08-29 | 2004-09-15 | Schering Corporation | Aerosolový suspenzní přípravek mometazonfuroátu bez chlorfluorovaných uhlovodíků |
| SE9700135D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
| US6495167B2 (en) * | 1997-03-20 | 2002-12-17 | Schering Corporation | Preparation of powder agglomerates |
| US6503537B2 (en) * | 1997-03-20 | 2003-01-07 | Schering Corporation | Preparation of powder agglomerates |
| TW533865U (en) * | 1997-06-10 | 2003-05-21 | Glaxo Group Ltd | Dispenser for dispensing medicament and actuation indicating device |
| GB2359749B (en) * | 1998-11-26 | 2004-05-05 | Britannia Pharmaceuticals Ltd | Anti-asthmatic combinations comprising surface active phospholipids |
| AR022695A1 (es) * | 1999-01-28 | 2002-09-04 | Schering Corp | PORTADOR SoLIDO PARTICULADO Y MÉTODO PARA PROVEER CONTROL DE LA PARTICULADA PARA LA DISTRIBUCIoN DE TAMANO DE PARTíCULAS Y DE CONTENIDO AMORFO CONVERTIBLE DURANTE SU PREPARACION |
| GB9904919D0 (en) * | 1999-03-03 | 1999-04-28 | Novartis Ag | Organic compounds |
| SE9900833D0 (sv) * | 1999-03-09 | 1999-03-09 | Astra Ab | Novel combination |
| US6156294A (en) * | 1999-11-28 | 2000-12-05 | Scientific Development And Research, Inc. | Composition and method for treatment of otitis media |
| MXPA02007052A (es) * | 2000-01-20 | 2002-12-13 | Basilea Pharmaceutica Ag | Composiciones que se administran nasalmente y que contienen peptidos ciclicos. |
| GB0009612D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Therapeutic formulations |
| AU2001278115A1 (en) * | 2000-08-04 | 2002-02-18 | Longwood Pharmaceutical Research, Inc. | Formulations of mometasone and a bronchodilator for pulmonary administration |
| TW200301698A (en) * | 2001-12-21 | 2003-07-16 | Bristol Myers Squibb Co | Acridone inhibitors of IMPDH enzyme |
-
2002
- 2002-08-26 TW TW091119250A patent/TWI324934B/zh not_active IP Right Cessation
- 2002-08-26 AR ARP020103194A patent/AR036358A1/es not_active Application Discontinuation
- 2002-08-27 EP EP09006110A patent/EP2092935B1/en not_active Expired - Lifetime
- 2002-08-27 AT AT02753549T patent/ATE430555T1/de active
- 2002-08-27 ES ES02753549T patent/ES2325316T3/es not_active Expired - Lifetime
- 2002-08-27 ES ES10012751T patent/ES2389480T3/es not_active Expired - Lifetime
- 2002-08-27 AU AU2002313828A patent/AU2002313828B2/en not_active Ceased
- 2002-08-27 BR BR0212089-5A patent/BR0212089A/pt not_active IP Right Cessation
- 2002-08-27 MX MXPA04001875A patent/MXPA04001875A/es active IP Right Grant
- 2002-08-27 HU HU0401514A patent/HUP0401514A3/hu unknown
- 2002-08-27 PT PT09006110T patent/PT2092935E/pt unknown
- 2002-08-27 DK DK09006110.2T patent/DK2092935T3/da active
- 2002-08-27 PE PE2002000820A patent/PE20030390A1/es not_active Application Discontinuation
- 2002-08-27 EP EP02753549A patent/EP1420759B1/en not_active Expired - Lifetime
- 2002-08-27 CA CA002457926A patent/CA2457926A1/en not_active Abandoned
- 2002-08-27 DK DK02753549T patent/DK1420759T3/da active
- 2002-08-27 WO PCT/US2002/027336 patent/WO2003020253A2/en not_active Ceased
- 2002-08-27 ES ES09006110T patent/ES2361805T3/es not_active Expired - Lifetime
- 2002-08-27 CN CN201010156400A patent/CN101856362A/zh active Pending
- 2002-08-27 NZ NZ530987A patent/NZ530987A/en not_active IP Right Cessation
- 2002-08-27 EP EP10012751A patent/EP2319494B1/en not_active Expired - Lifetime
- 2002-08-27 JP JP2003524562A patent/JP2005502675A/ja active Pending
- 2002-08-27 SI SI200230943T patent/SI2092935T1/sl unknown
- 2002-08-27 DE DE60232251T patent/DE60232251D1/de not_active Expired - Lifetime
- 2002-08-27 DE DE60239648T patent/DE60239648D1/de not_active Expired - Lifetime
- 2002-08-27 SI SI200230839T patent/SI1420759T1/sl unknown
- 2002-08-27 PT PT02753549T patent/PT1420759E/pt unknown
- 2002-08-27 KR KR1020047002778A patent/KR100970531B1/ko not_active Expired - Fee Related
- 2002-08-27 PL PL368897A patent/PL209640B1/pl not_active IP Right Cessation
- 2002-08-27 AT AT09006110T patent/ATE503461T1/de active
- 2002-08-27 CN CN02816685XA patent/CN1649568B/zh not_active Expired - Fee Related
- 2002-08-28 US US10/229,855 patent/US20030114428A1/en not_active Abandoned
-
2004
- 2004-02-16 CO CO04012909A patent/CO5560551A2/es not_active Application Discontinuation
- 2004-02-20 ZA ZA2004/01419A patent/ZA200401419B/en unknown
- 2004-03-26 NO NO20041277A patent/NO20041277L/no not_active Application Discontinuation
-
2005
- 2005-03-03 US US11/071,078 patent/US20050147565A1/en not_active Abandoned
-
2009
- 2009-05-26 JP JP2009126933A patent/JP2009185075A/ja active Pending
- 2009-07-08 CY CY20091100723T patent/CY1109212T1/el unknown
- 2009-12-08 US US12/633,510 patent/US20100143269A1/en not_active Abandoned
-
2010
- 2010-02-22 JP JP2010036706A patent/JP5170789B2/ja not_active Expired - Fee Related
-
2011
- 2011-06-28 CY CY20111100617T patent/CY1111726T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR036358A1 (es) | Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma | |
| DE60114571D1 (de) | Zubereitungen mit einem anticholinergischen wirkstoff für die behandlung der chronischen obstruktiven lungenerkrankung | |
| BG102689A (bg) | Фармацевтичен аерозолен състав за използване при лечение на респираторни смущения | |
| CY1122851T1 (el) | Υπερλεπτο σκευασμα φορμοτερολης | |
| KR970704422A (ko) | 투여용 약제학적 조성물 | |
| IS1768B (is) | Lyfjablanda til innöndunar sem inniheldur insúlín | |
| NZ243061A (en) | Aerosol containing a medicament and 1,1,1,2,3,3,3-heptafluoropropane | |
| AR013614A1 (es) | Nueva composicion que comprende una combinacion de esteroides, un kit que la contiene, el uso de la misma, el uso de dicho kit de formoterol y debudesonida en la fabricacion de un medicamento | |
| JO2430B1 (en) | Pharmaceutical formulas for dry powder inhalations in the form of solid pellets | |
| SI9200403B (en) | New combination of a bronchodilator and a steroidal antiinflammatory drug for treatment of respiratory disorders as well as its use and preparation thereof | |
| CA2353959A1 (en) | A medicinal aerosol formulation | |
| AR021922A1 (es) | Formulaciones farmaceuticas en aerosol que contienen fluoroalcanos, budesonido y formoterol. | |
| MY129512A (en) | Novel medicament compositions, based on tiotropium bromide and salmeterol | |
| MY129384A (en) | "pharmaceutical formulations for dry powder inhalers in the form of hard-pellets" | |
| UA89751C2 (ru) | Состав, который содержит сульфат альбутерола и бромид ипратропия, способ его получения и ингалятор | |
| TR200100144T2 (tr) | Farmasötik aerosol formülasyonu | |
| GB0323684D0 (en) | Improvements in or relating to organic compounds | |
| HUP9802391A2 (hu) | Inhaláló berendezés szalmeterol adagolására mért dózisban | |
| DE69205177D1 (de) | Pharmazeutische Aerosolformulierung. | |
| CO5031245A1 (es) | Inhaladores de dosis regulada a presion y formulaciones farmaceuticas de aerosol | |
| ATE418994T1 (de) | Argon enthaltendes arzneimittel zum inhalieren und dessen verwendung zur behandlung von neurotoxizität | |
| ES2134634T3 (es) | Composiciones farmaceuticas y dispositivos para su administracion. | |
| BG107257A (en) | Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases | |
| MX2023003754A (es) | Formulacion farmaceutica para inhalador presurizado de dosis medidas. | |
| FI962056A0 (fi) | Uusi farmaseuttinen koostumus stabiilin jauheen valmistamiseksi, joka sisältää asetyylisalisyylihapon ja metoklopramidin yhdistelmän käsittävän aktiivisen aineosan |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |